GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Inventory-to-Revenue

Krebs Biochemicals & Industries (BOM:524518) Inventory-to-Revenue : 0.82 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Krebs Biochemicals & Industries's Average Total Inventories for the quarter that ended in Mar. 2024 was ₹98.0 Mil. Krebs Biochemicals & Industries's Revenue for the three months ended in Mar. 2024 was ₹119.7 Mil. Krebs Biochemicals & Industries's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.82.

Krebs Biochemicals & Industries's Inventory-to-Revenue for the quarter that ended in Mar. 2024 declined from Dec. 2023 (0.86) to Dec. 2023 (0.82)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Krebs Biochemicals & Industries's Days Inventory for the three months ended in Mar. 2024 was 309.23.

Inventory Turnover measures how fast the company turns over its inventory within a year. Krebs Biochemicals & Industries's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.30.


Krebs Biochemicals & Industries Inventory-to-Revenue Historical Data

The historical data trend for Krebs Biochemicals & Industries's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krebs Biochemicals & Industries Inventory-to-Revenue Chart

Krebs Biochemicals & Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.41 0.35 0.36 0.22

Krebs Biochemicals & Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 1.13 0.75 0.86 0.82

Competitive Comparison of Krebs Biochemicals & Industries's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Krebs Biochemicals & Industries's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krebs Biochemicals & Industries's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krebs Biochemicals & Industries's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Krebs Biochemicals & Industries's Inventory-to-Revenue falls into.



Krebs Biochemicals & Industries Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Krebs Biochemicals & Industries's Inventory-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Inventory-to-Revenue (A: Mar. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Mar. 2023 ) + Total Inventories (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )
=( (119.456 + 97.964) / 2 ) / 504.215
=108.71 / 504.215
=0.22

Krebs Biochemicals & Industries's Inventory-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue (Q: Mar. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Mar. 2024 )) / count ) / Revenue (Q: Mar. 2024 )
=( (0 + 97.964) / 1 ) / 119.729
=97.964 / 119.729
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krebs Biochemicals & Industries  (BOM:524518) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Krebs Biochemicals & Industries's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2024 )/Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=97.964/28.908*365 / 4
=309.23

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Krebs Biochemicals & Industries's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2024 ) / Average Total Inventories (Q: Mar. 2024 )
=28.908 / 97.964
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krebs Biochemicals & Industries Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Krebs Biochemicals & Industries (BOM:524518) Business Description

Traded in Other Exchanges
Address
Road No. 8, Banjara Hills, 8-2-577/B, Plot No. 34, 3rd Floor, Maas Heights, Hyderabad, TG, IND, 500 034
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries (BOM:524518) Headlines

No Headlines